secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K
Filed at:   2023-07-26T23:59:59+00:00
Accession:  0001493152-23-025571
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Propanc Biopharma enters $5M equity line with Dutchess Capital at 85% discount
------------------------------------------------------------------------------

- Up to $5M of common stock sales over 24 months; purchase price 85% of lowest trading price during 7-day pricing period.
- Maximum drawdown per notice: the lesser of $200,000 or 200% of 5-day average daily trading value; minimum $5,000 per notice.
- Per drawdown, cannot exceed 52.5M shares or cause investor ownership above 4.99% of outstanding shares.
- Proceeds used for R&D, clinical study manufacturing, working capital, and general corporate purposes.
- Registration statement must be effective before any drawdown; registration rights agreement requires filing within 45 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000149315223025571/0001493152-23-025571-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000149315223025571/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-025571

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer